EP3242887
GIP og GLP-1 samverkandi efnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.1.2016EP published:
14.8.2019EP application number:
16703620.1
EP translation filed:
21.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
4.1.2036Expiry date:
4.1.2027Next due date:
31.1.2027
Title:
GIP AND GLP-1 CO-AGONIST COMPOUNDS
Timeline
Today
5.1.2016EP application
14.8.2019EP Publication
21.8.2019Translation submitted
15.9.2019Registration published
4.1.2027Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
ALSINA-FERNANDEZ, JorgeAddress:
Indianapolis, Indiana, US
Name:
BOKVIST, Bengt KristerAddress:
Indianapolis, Indiana, US
Name:
COSKUN, TamerAddress:
Indianapolis, Indiana, US
Name:
CUMMINS, Robert ChadwickAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562101488 PDate:
9.1.2015Country:
US
Supplementary protection
SPC number:
SPC419
Classification
Categories:
C07K 14/575, C07K 14/605, A61K 38/26
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 4.11.2019
Expires: 4.1.2021
Payer: Árnason Faktor
Number: 6
Paid: 17.12.2020
Expires: 4.1.2022
Payer: Patice ehf.
Number: 7
Paid: 15.12.2021
Expires: 4.1.2023
Payer: Patice ehf.
Number: 8
Paid: 22.12.2022
Expires: 4.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 20.12.2023
Expires: 4.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 27.12.2024
Expires: 4.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.1.2026
Expires: 4.1.2027
Payer: Árnason Faktor ehf.